These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37652938)

  • 1. Boosting T cell immunity against cytomegalovirus: a potential strategy combating human aging and age-related diseases.
    Wirth M; Brenner W; Krämer OH
    Signal Transduct Target Ther; 2023 Sep; 8(1):325. PubMed ID: 37652938
    [No Abstract]   [Full Text] [Related]  

  • 2. T-cell immunity against cytomegalovirus in HIV infection and aging: relationships with inflammation, immune activation, and frailty.
    Tavenier J; Margolick JB; Leng SX
    Med Microbiol Immunol; 2019 Aug; 208(3-4):289-294. PubMed ID: 30900090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinfection with Human Cytomegalovirus Genetic Variants in Transplant Recipients and Its Impact on Antiviral T Cell Immune Reconstitution.
    Smith C; Brennan RM; Tey SK; Smyth MJ; Burrows SR; Miles JJ; Hill GR; Khanna R
    J Virol; 2016 Aug; 90(16):7497-507. PubMed ID: 27279616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promising Cytomegalovirus-Based Vaccine Vector Induces Robust CD8
    Liu J; Jaijyan DK; Tang Q; Zhu H
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal 513 amino acids of the envelope glycoprotein gB of human cytomegalovirus stimulates both B- and T-cell immune responses in humans.
    Liu YN; Klaus A; Kari B; Stinski MF; Eckhardt J; Gehrz RC
    J Virol; 1991 Mar; 65(3):1644-8. PubMed ID: 1847481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.
    Alp NJ; Allport TD; Van Zanten J; Rodgers B; Sissons JG; Borysiewicz LK
    J Virol; 1991 Sep; 65(9):4812-20. PubMed ID: 1714519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive in vitro effects of T-cell growth cytokines on cytomegalovirus-stimulated T-cell responses of HIV-infected HAART recipients.
    Patterson J; Jesser R; Weinberg A
    Virology; 2008 Aug; 378(1):48-57. PubMed ID: 18572217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CMV upon immune aging: facts and fiction.
    Jergović M; Contreras NA; Nikolich-Žugich J
    Med Microbiol Immunol; 2019 Aug; 208(3-4):263-269. PubMed ID: 31004198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options for T-cell based therapies.
    Heslop HE; Gottschalk SM; Bollard CM; Straathof KC; Huls MH; Brenner MK; Rooney CM
    Vox Sang; 2004 Jul; 87 Suppl 2():230-4. PubMed ID: 15209923
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products.
    Rice GP; Schrier RD; Oldstone MB
    Proc Natl Acad Sci U S A; 1984 Oct; 81(19):6134-8. PubMed ID: 6091137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytomegalovirus on lectin-driven mitogenesis of human thymic and peripheral blood lymphocytes.
    Numazaki K; Destephano L; Goldman H; Wong I; Wainberg MA
    In Vivo; 1988; 2(2):133-8. PubMed ID: 2856520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients.
    Zavaglio F; Vitello D; Bergami F; Arena F; Borsani O; Colombo AA; Caldera D; Lilleri D; Cassaniti I; Bernasconi P; Baldanti F
    J Clin Virol; 2023 Aug; 165():105519. PubMed ID: 37321150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames.
    Dhanwani R; Dhanda SK; Pham J; Williams GP; Sidney J; Grifoni A; Picarda G; Lindestam Arlehamn CS; Sette A; Benedict CA
    J Virol; 2021 Oct; 95(21):e0094021. PubMed ID: 34379494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in cytomegalovirus-specific T-cell immunity with immunomodulation in serodiscordant high-risk transplant recipients.
    Tinkham T; Song CC; Winstead R; Yakubu I; Brown A; Sterling S; Gupta G; Kumar D
    Transpl Infect Dis; 2021 Aug; 23(4):e13678. PubMed ID: 34181802
    [No Abstract]   [Full Text] [Related]  

  • 15. A Fully Protective Congenital CMV Vaccine Requires Neutralizing Antibodies to Viral Pentamer and gB Glycoprotein Complexes but a pp65 T-Cell Response Is Not Necessary.
    Choi KY; McGregor A
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa).
    Couzi L; Pitard V; Sicard X; Garrigue I; Hawchar O; Merville P; Moreau JF; Déchanet-Merville J
    Blood; 2012 Feb; 119(6):1418-27. PubMed ID: 22180442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector.
    Quinn M; Erkes DA; Snyder CM
    Immunotherapy; 2016 Feb; 8(2):211-21. PubMed ID: 26786895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation.
    Peggs KS; Verfuerth S; Pizzey A; Chow SL; Thomson K; Mackinnon S
    Clin Infect Dis; 2009 Dec; 49(12):1851-60. PubMed ID: 19911966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires.
    Wang C; Liu Y; Xu LT; Jackson KJ; Roskin KM; Pham TD; Laserson J; Marshall EL; Seo K; Lee JY; Furman D; Koller D; Dekker CL; Davis MM; Fire AZ; Boyd SD
    J Immunol; 2014 Jan; 192(2):603-11. PubMed ID: 24337376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity.
    Reddehase MJ; Mutter W; Münch K; Bühring HJ; Koszinowski UH
    J Virol; 1987 Oct; 61(10):3102-8. PubMed ID: 3041033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.